Valeant Pharma adds hedge fund executive, 2 others to board

Embattled drug company Valeant Pharmaceuticals has added three directors to its board, including an executive from activist investor Bill Ackman's hedge fund Pershing Square Capital Management.

See Full Article

Its shares climbed nearly 4 per cent in premarket trading shortly ahead of the Wednesday market open.

The Canadian drugmaker said Wednesday that Pershing Vice Chairman Stephen Fraidin has joined the board, along with pharmaceutical executive Dr. Fred Eshelman and former University of North Carolina president Thomas W. Ross. Dr. Anders Lonner also is leaving, so these moves will bump the board's size to 14 members, 12 of whom are independent.

Pershing Square holds a 6.3 per cent stake in Valeant, as one of its biggest shareholders, according to FactSet.

Fraidin is an attorney specializing in mergers and acquisitions. Eshelman is the founder and former CEO of Pharmaceutical Product Development Inc. and has worked in the pharmaceutical industry for 35 years, Valeant said.

Valeant Pharmaceuticals International Inc. is facing a Securities and Exchange Commission investigation and, separately, scrutiny from Congress over its drug pricing. CEO Michael Pearson also recently returned to work after missing two months due to some health problems.

Valeant will discuss its preliminary fourth-quarter results and update its forecast for 2016 on March 15. The company had said last month it was delaying that announcement due to Pearson's return to work.

The company also has said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor, which has raised questions about the accuracy of Valeant's financial reporting.

U.S.-traded shares of Valeant jumped nearly 4 per cent, or $2.49, to $65.64 shortly before markets opening Wednesday. That's about a quarter of the all-time high of $263.81 that the stock reached in August, shortly before the company's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny.



Advertisements

Latest Economic News

  • Marijuana company Aphria met with TSX about guidance regarding U.S. business

    Economic CBC News
    Marijuana producer Aphria Inc. says it met with the Toronto Stock Exchange last week to discuss the exchange's recent guidance that pot firms with U.S. exposure could face delisting. Aphria chief executive Vic Neufeld says the company reiterated its commitment to work collaboratively with the TSX as it continues to monitor developments in this sector. Source
  • Bombardier manager goes to jail for defrauding company to fund lavish lifestyle

    Economic CTV News
    MONTREAL -- A former manager of Bombardier Inc.'s railway division in Britain was sentenced Monday to six years in prison for defrauding the firm of about $1.15 million which he used to fund a lavish lifestyle. Source
  • Amazon says it received 238 bids for its second headquarters, HQ2

    Economic CBC News
    Amazon said Monday that it received 238 proposals from cities and regions in the United States, Canada and Mexico hoping to be the home of the company's second headquarters. At least 11 Canadian locations submitted bids, scattered across 6 provinces. Source
  • Amazon says it received 238 proposals for 2nd headquarters

    Economic CTV News
    NEW YORK -- Amazon says it received 238 proposals from cities and regions hoping to be the home of the company's second headquarters. The online retailer kicked off its hunt for a second headquarters in September, promising to bring 50,000 new jobs and spend up to $5 billion. Source
  • As Bank of Canada ponders another rate hike, survey suggests many are really feeling the last ones

    Economic CBC News
    As the Bank of Canada prepares to announce its latest decision on interest rates, a new survey suggests a growing number of Canadians think they would be in financial trouble if rates rise again. A survey released Monday by Canada's biggest insolvency firm, MNP Ltd. Source
  • HBC minority shareholder calls for special meeting to replace board of directors

    Economic CBC News
    A U.S. investment firm is calling for the removal of the current board of directors at Hudson's Bay Co., and taking particular aim at its executive chairman. Hudson's Bay Co.'s management has been under pressure for months from Land & Buildings Investment Management, which argues HBC's stock price is undervalued. Source
  • Just For Laughs mandates RBC Capital Markets to look into sale of Rozon shares

    Economic CTV News
    MONTREAL -- Just For Laughs says it has mandated RBC Capital Markets to look into the various possible options surrounding the sale of founder Gilbert Rozon's shares in the comedy festival. The organization made the announcement this morning. Source
  • Sask. Premier Brad Wall hits pause on planned corporate tax

    Economic CTV News
    REGINA -- Saskatchewan Premier Brad Wall says the government will pause a corporate tax cut outlined in the provincial budget in March. The government said in the budget that the corporate tax rate would go from 12 per cent to 11.5 per cent at the start of July, and then down another half point to 11 per cent on July 1, 2019. Source
  • Sask. Premier Brad Wall hits pause on planned corporate tax cut

    Economic CTV News
    REGINA -- Saskatchewan Premier Brad Wall says the government will pause a corporate tax cut outlined in the provincial budget in March. The government said in the budget that the corporate tax rate would go from 12 per cent to 11.5 per cent at the start of July, and then down another half point to 11 per cent on July 1, 2019. Source
  • Statistics Canada says wholesale sales gained 0.5 per cent in August

    Economic CTV News
    OTTAWA -- Statistics Canada says wholesale sales rose 0.5 per cent to $62.8 billion in August. The agency says the increase led by the personal and household goods and motor vehicle and parts subsectors. Source